| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/16/2005 | EP0853672B1 DNA SEQUENCES CODING FOR A CINNAMOYL CoA REDUCTASE, AND APPLICATIONS THEREOF IN THE CONTROL OF LIGNIN CONTENTS IN PLANTS |
| 02/16/2005 | EP0846160B1 Methods for enhancing the production of viral vaccines in cell culture by interferon suppression |
| 02/16/2005 | EP0634896B1 Evaluation of patients with progressive immunosuppression |
| 02/16/2005 | CN1582341A Method of isolating cells and uses thereof |
| 02/16/2005 | CN1582340A Receptor capture assay |
| 02/16/2005 | CN1582339A Method for the amplificaton and detection of DNA using a transcription based amplification |
| 02/16/2005 | CN1582338A Sulfated fucogalactan digesting enzyme gene |
| 02/16/2005 | CN1582337A 丙型肝炎病毒疫苗 Hepatitis C Virus Vaccine |
| 02/16/2005 | CN1582336A Moraxella (branhamella) catarrhalis antigens |
| 02/16/2005 | CN1582335A Rice transposon genes |
| 02/16/2005 | CN1582334A Potentionmetric DNA microarray, Process for producing same and method of analyzig nucleuic acid |
| 02/16/2005 | CN1582332A GFP-transfected clon pig, GT knoc-out clon pig and methos for production thereof |
| 02/16/2005 | CN1582330A In-vitro micro-organs and uses realated thereto |
| 02/16/2005 | CN1582329A New biopesticide using gene from erwinia pyrifoliaeWT#3, novel pathogen that affects asian pear trees |
| 02/16/2005 | CN1582301A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/16/2005 | CN1582297A Hybrid and tandem expression of neisserial proteins |
| 02/16/2005 | CN1582295A Novel epidermal growth factor protein and gene, and methods of use therefor |
| 02/16/2005 | CN1582178A Hematopoietic stem cell gene therapy |
| 02/16/2005 | CN1582165A Antibodies to CD40 |
| 02/16/2005 | CN1580771A Method for recording signals |
| 02/16/2005 | CN1580266A Method for extablishing polymorphism adenoid tumour mouse model |
| 02/16/2005 | CN1580265A T-20 fusion protein, and its preparing method and use |
| 02/16/2005 | CN1580264A High soluble expressed tricholsanthin mutant and its preparing method |
| 02/16/2005 | CN1580263A Interleukin-2 and enterotoxin A fusion gene and its preparation |
| 02/16/2005 | CN1580262A Carrier system containing artificial transcription factor regulated by oxygen deficit, and its configuration and use |
| 02/16/2005 | CN1580261A CC10 protein preparation and use |
| 02/16/2005 | CN1580260A SiRNA and expression carrier for inhibiting human telomerase reversed transcriptive enzyme gene expression and their pharmaceutical use |
| 02/16/2005 | CN1580259A SiRAN and expression carrier for inhibiting human VEGF gene expression and their pharmaceutical use |
| 02/16/2005 | CN1580258A SiRNA and expression plasmid for inhibiting human bc1-2 gene expression and their use for preparing medicine |
| 02/16/2005 | CN1580257A Method for breeding transgenic wheat and its use |
| 02/16/2005 | CN1580251A Method for efficiently establishing pure line gene knock-out mouse model |
| 02/16/2005 | CN1580249A Method for screening and establishing mouse-development-related gene mutation ES cell bank |
| 02/16/2005 | CN1580244A Pentaose fermenting bacteria character conversion microbe |
| 02/16/2005 | CN1580072A SARS coronary virus nail protein high-immune-protosegment, coding sequence and its use |
| 02/16/2005 | CN1580070A Anti HBV infection and hepatitis B-preventing nucleotide sequence and its use |
| 02/16/2005 | CN1580069A Interleukin-2 and enterotoxin B fusion gene and its preparation |
| 02/16/2005 | CN1189573C Microarray-based analysis of polycleotide sequence variations |
| 02/16/2005 | CN1189565C Efficient prokaryotic expression carrier |
| 02/16/2005 | CN1189564C Modulators of the function of receptors of the TNF/NGF receptor family |
| 02/16/2005 | CN1189563C Cloning-free linear expression vector constituting method |
| 02/16/2005 | CN1189562C Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase |
| 02/16/2005 | CN1189558C Amylase variants |
| 02/16/2005 | CN1189556C Improved riboflavin prodn. |
| 02/16/2005 | CN1189484C Recombined human CD11a monclone antibody and its preparation and medicinal composition |
| 02/16/2005 | CN1189483C Humanized CD3-resisting monoclonal antibody |
| 02/16/2005 | CN1189482C Novel angiogenesis inhibitor |
| 02/16/2005 | CN1189481C Human truncated recombination soluble TRAIL-170 protein and application for preparing tumour-curing medicine thereof |
| 02/16/2005 | CN1189480C Overreationg factor as well as its preparation factor and gene |
| 02/16/2005 | CN1189213C Tolerance to xenograft |
| 02/15/2005 | US6856915 Methods of identifying organism based on its genotype |
| 02/15/2005 | US6855873 Comprises nucleotide sequences coding bacterial protoxin protein for generating insect resistant plants |
| 02/15/2005 | US6855872 Tolerance of trichothecene mycotoxins in plants through the modification of the ribosomal protein L3 gene |
| 02/15/2005 | US6855871 Transgenic plant for use in generation and maintenance of preferential storage proteins in seeds |
| 02/15/2005 | US6855869 Phytic acid biosynthetic enzymes |
| 02/15/2005 | US6855868 Geranylgeranyl pyrophosphate synthases |
| 02/15/2005 | US6855866 Regulatory sequences which control RNA biosynthesis for evaluating embryogenesis in plants; tissue engineering and gene expression |
| 02/15/2005 | US6855865 Nucleotide sequences coding cysteine-rich proteins for generation of disease/insect/fungal/nematode resistant dicots/monocots |
| 02/15/2005 | US6855864 Methods for simultaneous control of lignin content and composition, and cellulose content in plants |
| 02/15/2005 | US6855862 Isolated DNA sequences encoding a flavonoid 5-glucosytransferase and methods of use thereof |
| 02/15/2005 | US6855816 Method for producing endotoxin-free nucleic acids and the use thereof |
| 02/15/2005 | US6855812 P-glycoproteins and uses thereof |
| 02/15/2005 | US6855810 Ligands directed to the non-secretory component, non-stalk region of plgR and methods of use thereof |
| 02/15/2005 | US6855809 Chimeric immunoglobulin for detecting hepatitis c viral (HVC) infections and/or contaminated blood products; diagnosis and viral diseases |
| 02/15/2005 | US6855808 Prevent cell differentiation; culture product; genetic engineered protein |
| 02/15/2005 | US6855807 Heterodimeric opioid G-protein coupled receptors |
| 02/15/2005 | US6855806 Comprises secreted polypeptide for diagnosis and treatment of tumors, nervous system, reproductive and muscular disorder |
| 02/15/2005 | US6855803 Protein having hemolytic activity and gene encoding the protein |
| 02/15/2005 | US6855802 Mutated peptide compounds, derived from hsp70, useful in cancer immunotherapy |
| 02/15/2005 | US6855736 Molecular target of neurotoxicity |
| 02/15/2005 | US6855701 Administering a nucleic acid to express a gene product in cells by treating the tissue to increase vascular permeability of exogenous nucleic acid; administering exogenous nucleic acid to the tissue; low calcium ion |
| 02/15/2005 | US6855700 Antisense modulation of damage-specific DNA binding protein 1, p127 expression |
| 02/15/2005 | US6855688 ADP-ribosyl transferase fusion proteins, pharmaceutical compositions, and methods of use |
| 02/15/2005 | US6855683 Hypersensitive response elicitor from Erwinia amylovora, its use, and encoding gene |
| 02/15/2005 | US6855560 Detecting regulators of G-protein coupled receptor activity for treating nervous system, psychological, obesity and hypertensive disorders |
| 02/15/2005 | US6855550 Genetically engineered microorganism for use as tools in the generation of heterologous binding proteins |
| 02/15/2005 | US6855549 Methods and compositions for increasing the infectivity of gene transfer vectors |
| 02/15/2005 | US6855545 Indexed library of cells containing genomic modifications and methods of making and utilizing the same |
| 02/15/2005 | US6855544 Expressing heterologous polypeptide in eukaryotic tissue; tissue engineering |
| 02/15/2005 | US6855534 Enhanced system for construction of adenovirus vectors |
| 02/15/2005 | US6855533 Structure-based designed herbicide resistant products |
| 02/15/2005 | US6855532 Gene therapy; drug screening |
| 02/15/2005 | US6855531 Enzymatic polypeptide for use in paper making, detergents and textile processing |
| 02/15/2005 | US6855529 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants |
| 02/15/2005 | US6855525 Generating ethyl 4-chloroacetoacetate via fermentation in ralstonia culture; fatty acid biosynthesis |
| 02/15/2005 | US6855523 For rapid sensitive, standardized detection of target nucleic acid from pathogenic microorganism or virus or normal or abnormal gene |
| 02/15/2005 | US6855520 Cell volume-regulated human kinase h-sgk |
| 02/15/2005 | US6855519 Methods for enhancing the production of interferon in cell culture |
| 02/15/2005 | US6855518 Anti-listeria bacteriocin |
| 02/15/2005 | US6855517 Compositions and methods relating to breast specific genes and proteins |
| 02/15/2005 | US6855516 Gene conferring lysozyme insensitivity to corynebacterium |
| 02/15/2005 | US6855510 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 02/15/2005 | US6855502 Hyaluronate synthase gene and uses thereof |
| 02/15/2005 | US6855500 Fluorescence-based genotyping |
| 02/15/2005 | US6855499 Magnetic isolation and purification of nucleic acids |
| 02/15/2005 | US6855496 Detection of preferential nucleic acid ligands; obtain nucleotide sequences, incubate with oligonucleotides, hybridize, amplify, recover nucleotide sequences |
| 02/15/2005 | US6855494 Method for increasing viability and transformation efficiency of bacteria during storage at low temperatures |
| 02/15/2005 | US6855365 Recombinant bacterial phytases and uses thereof |
| 02/15/2005 | US6855323 Identification of the domain of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) that mediates adhesion to chondroitin sulfate A |
| 02/15/2005 | US6855322 A highly purified protein, Plasmodium falciparum MSP-142, which retains folding and disulfide bridging of the native molecule and is useful as a diagnostic reagent, antibody production, and as a vaccine for malaria |
| 02/15/2005 | US6855321 Polyepitope carrier protein |